Institute for Psychosocial Prevention, University of Heidelberg, Bergheimer Str. 54, 69115, Heidelberg, Germany.
Curr Psychiatry Rep. 2019 Mar 9;21(4):25. doi: 10.1007/s11920-019-1012-5.
This review aims to outline the most recent evidence on the efficacy and effectiveness of mentalization-based treatment (MBT) for personality disorders (PD) from 2015 to 2018 and to describe new treatment developments.
Since 2015, 14 new-primarily effectiveness-MBT trials have been published. The main body of studies investigated adult populations (n = 11), patients with a borderline personality disorder (BPD) diagnosis (n = 8), and compared MBT with another psychotherapeutic treatment (n = 6). The majority of studies suggest that MBT has the potential to improve the clinical outcomes for adolescents and adults with a PD diagnosis, particularly BPD, and also with comorbid diagnoses and there are indications for changes in mentalizing being a specific mechanism of change promoted by MBT. Despite promising findings, there is an urgent need for methodological sound and sufficiently powered studies to investigate both the efficacy and effectiveness of MBT, especially beyond BPD.
本综述旨在概述 2015 年至 2018 年间,心理化治疗(MBT)治疗人格障碍(PD)的最新疗效和有效性证据,并描述新的治疗进展。
自 2015 年以来,已经发表了 14 项新的主要是有效性的 MBT 试验。这些研究主要针对成年人群(n=11),以及患有边缘型人格障碍(BPD)诊断的患者(n=8),并将 MBT 与另一种心理治疗方法进行了比较(n=6)。大多数研究表明,MBT 有可能改善 PD 诊断,尤其是 BPD 患者的青少年和成年患者的临床结局,对于合并诊断的患者也有改善,并且表明心理化的改变是 MBT 促进的特定改变机制。尽管有很有前景的发现,但迫切需要进行方法合理且具有足够效力的研究,以调查 MBT 的疗效和有效性,尤其是针对 BPD 以外的疾病。